MET and renal carcinoma: In our previous studies5,13,15, we reported that the anti-oxidant cytoprotective molecule HO-1 is over-expressed in renal cancer; and c-Met can induce HO-1 through the transcription factor Nrf2, which is considered to be its master regulator.